Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Initial research reported individuals lost significant body weight following treatment with retatrutide, with some losing over 20% of their body weight
Pharmacy Licensing and Interstate Dispensing Pharmacy Must: Be licensed by your states board of pharmacy, OR Participate in interstate pharmacy compact allowing cross-state dispensing Compounding Pharmacy Considerations: 503A Pharmacies: Traditional compounding pharmacies Must hold pharmacy license in patients state Can ship to states where licensed State board of pharmacy regulates 503B Outsourcing Facilities: Registered with FDA (federal) Can ship across state lines more easily Still need to comply with state laws FDA inspects and regulates Verifying Pharmacy Authorization: Check if pharmacy holds license in your state (state board website) For 503B: Check FDA registered outsourcing facilities list Legitimate providers only use properly licensed pharmacies Controlled Substance Regulations Good News for GLP-1s: Semaglutide and tirzepatide are NOT controlled substances , making telehealth prescribing straightforward
Here is how to think about it without turning this into four separate diet plans
Per HumeCare's own disclosures, GLP-1 clinical services are not currently available in Alabama, Arkansas, Louisiana, or Mississippi
This dual-direction approach explains why retatrutide results showed greater weight loss in a shorter period without participants reaching a metabolic plateau where the body adapts and weight loss stalls
